ALCON LABORATORIES, INC. for ALCON LABORATORIES INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2010 | $180,000 | Replaced |
| 3rd Quarter - Amendment | Nov 24, 2010 | $200,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
510K regulatory approval process for medical devices.
Foreign entity interest: Novartis AG, a foreign Swiss entity, is the majority owner of Alcon, Inc. as of August 25, 2010 when they purchased the remainder of Nestle, SAs interests. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETTE MCCLELLAN | — |
Medicare/Medicaid MMM
Issues concerning Medicare reimbursement for ambulatory surgical center and hospital outpatient prospective payment systems.
Foreign entity interest: Novartis AG, a foreign Swiss entity, is the majority owner of Alcon, Inc. as of August 25, 2010 when they purchased the remainder of Nestle, SAs interests. Alcon Laboratories, Inc. is a subsidiary of Alcon Holdings, Inc. Alcon Holdings, Inc. is a subsidiary of Alcon, Inc. Alcon, Inc. is a foreign entity incorporated in Zug, Switzerland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRETTE MCCLELLAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.